A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma

Cancer Research

Volumn 56, Issue 2, 1996, Pages 254-258

  Jean, Didier ^a   Bar Eli, Menashe ^b   Huang, Suyun ^b   Xie, Keping ^b   Rodrigues Lima, Fernando ^a   Hermann, Jacques ^a   Frade, Raymond ^a  

^a INSERM   (France)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; COMPLEMENT COMPONENT C3; CYSTEINE PROTEINASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CARCINOGENESIS;

ANIMALS; CATHEPSINS; COMPLEMENT C3; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; EPITOPES; HUMANS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0030032540     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Muller-Eberhard, H. J., and Schreiber, R D Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol., 29: 1-53, 1980.
2. Harrison, R. A., and Lachman, P. J. The physiological breakdown of the third component of human complement. Mol. Immunol., 17: 9-20, 1980.
3. Frade, R., Myones, B. L., Barel, M , Krikorian, L., Charriaut, C., and Ross, C. D. Gp140, a C3b binding membrane component of B lymphocytes is the C3d/C3dg receptor (CR2) and is distinct from the neutrophils C3dg receptor (CR4) Eur. J. Immunol., 15. 1192-1197, 1985.
4. Frade, R., Hermann, J., and Barel, M. A 16 amino acid synthetic peptide derived from human C3d, triggers proliferation and specific tyrosine- phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes Biochem. Biophys Res. Commun., 188: 833-842, 1992
5. 125I-C3b, the third component of complement, after binding to human cells Eur J. Immunol., 12: 289-294, 1982.
6. Charriaut-Marlangue, C., Barel, M., and Frade, R. Identification of p57, a serine proteinase, from human erythrocyte membranes, which cleaves both chains of human third component (C3) of complement. Biochem. Biophys. Res. Commun., 140:1113-1120, 1986.
7. Hermann, J., Barel, M., and Frade, R. Human erythrocyte ankyrin, a cytoskeleton component generates the p57 membrane proteinase which cleaves C3, the third component of complement. Biochem. Biophys. Res. Commun , 204: 453-460, 1994.
8. Ollert, M. W., Frade, R., Fiandino, A., Panneerselvam, M , Petrella, E. C , Barel, M , Pangburn, M. K., Bredehorst, R., and Vogel, C. W. C3-cleaving proteinase: a new complement regulatory protein of human melanoma cells J Immunol., 144: 3862-3867, 1990
9. Jean, D., Hermann, J., Rodrigues-Lima, F., Barel, M , Balbo, M., and Frade, R Identification on melanoma cells of p39, a cysteine proteinase which cleaves C3, the third component of complement: amino acid sequence identifies with procathepsin L Biochem. J., 312: 961-969, 1995.
10. Zhang, R D , Price, J. E., Schackert, G , Itoh, K., and Fidler, I. J. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Cancer Res., 51: 2029-2035, 1991.
11. McCready, D. R., Balch, C. M., Fidler, I. J., and Murray, J. L. Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo. J. Natl. Cancer Inst., 81: 682-687, 1989.
12. Pathak, S., Drwinga, H L., and Hsu, T. C. Cytogenet: involvement of chromosome 6 rearrangements in human malignant melanoma cell lines. Cell Genet., 36: 573-579, 1983.
13. Smith, P. K., Krohn, R I , Hermanson, G T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoro, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C Anal. Biochem., 150: 76-85, 1985
14. Laemmli, U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
15. Barel, M., Fiandino, A., Lyamani, F., and Frade, R. Epstein-Barr virus, complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein detection by polyclonal anti-idiotypic anti-CR2 antibodies. Proc. Natl. Acad. Sci. USA, 86: 10054-10058, 1989.
16. Luca, M., Hunt, B., Bucana, C. D., Johnson, J. P., Fidler, I. J., and Bar-Eli, M Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res, 3: 35-41, 1993.
17. Radinsky, R., Fidler, I. J , Price, J E., Esumi, N., Tsan, R., Petty, C M., Bucana, C. D , and Bar-Eli, M. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene, 9: 1877-1833, 1994.
18. INKA/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogenes, 11: 1399-1402, 1995.
19. Singh, R. K., Gutman, M., Reich, R., and Bar-Eli, M. Ultraviolet B irradiation promotes tumongenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res., 55: 3669-3674, 1995.
20. Smith, S. M., Kane, S. E , Gal, S., Mason, R W., and Gottesman, M. M. Glycosylation of procathepsin L does not account for species molecular-mass differences and is not required for proteolytic activity. Biochem. J., 262: 931-938, 1989.
21. Gal, S., and Gottesman, M. M. Isolation and sequence of cDNA for human pro-(cathepsin L) Biochem. J , 253. 303-306, 1988.
22. Chauhan, S. S., Goldstein, L. J., and Gottesman, M. M. Expression of cathepsin L in human tumors. Cancer Res., 51: 1478-1481, 1991.
23. Rozhin, J., Wade, R. L , Honn, K. V., and Sloane, B. F Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem. Biophys. Res. Commun., 164: 556-561, 1989
24. Maciewicz, R. A., Wardale, R. J., Etherington, D. J., and Paraskeva, C Immunodetection of cathepsin B and L present in and secreted from human pre-malignant and malignant colorectal tumor cell lines. Int. J Cancer, 43: 478-486, 1989.
25. Thomssen, C., Schmitt, M., Goretzki, L , Oppelt, P., Pache, L , Dettmar, P., Janicke, F , and Graeff, H Prognostic values of the cysteine proteases cathepsins B and cathepsin L in human breast Cancer Clin. Cancer Res., 1: 741-746, 1995